product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
DNMT3B (D7O7O) Rabbit mAb
catalog :
67259
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D7O7O
reactivity :
human
application :
western blot, immunocytochemistry
more info or order :
Cell Signaling Technology product webpage
citations: 2
Published Application/Species/Sample/DilutionReference
  • immunocytochemistry; human; loading ...; fig s7b
  • western blot; human; loading ...; fig 2c
Liu S, Liu L, Xu G, Cao Z, Wang Q, Li S, et al. Epigenetic Modification Is Regulated by the Interaction of Influenza A Virus Nonstructural Protein 1 with the De Novo DNA Methyltransferase DNMT3B and Subsequent Transport to the Cytoplasm for K48-Linked Polyubiquitination. J Virol. 2019;93: pubmed publisher
  • western blot; human; fig 6d
Jung J, Kim L, Wang X, Wu Q, Sanvoranart T, Hubert C, et al. Nicotinamide metabolism regulates glioblastoma stem cell maintenance. JCI Insight. 2017;2: pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.